CSI Market
Sign In | Register

Gw Pharmaceuticals Plc (GWPH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access GWPH Annual Cash Flow →
Examining cash flow movements between Gw Pharmaceuticals Plc and Mar 31 2020 reveals how Mar 31 2021 allocates cash as operating conditions evolve.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2021)
3 Months 		(Dec 31 2020) (Sep 30 2020) (Jun 30 2020) (Mar 31 2020)
Operating Activities
Income-19.68
Depreciation & amortization2.90
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories7.91
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Intangible Assets0.00
Share-based Compensation16.83
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction-0.57
Foreign Exchange Gain Loss Before Tax0.54
Increase Decrease In Other Liabilities-2.91
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable13.80
Increase (Decrease) in Accounts Payable-3.89
Increase (Decrease) in Accrued Liabilities9.15
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-6.37
Other Working Capital-0.99
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-11.72
Investing Activities
Capital Expenditures7.94
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-10.83
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock2.33
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net7.69
Other net-494.52
Payments On Build To Suit Financing Obligation-
Payments On Landlord Financing Obligation-0.17
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations486.75
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-5.61
Effect of exchange rate on cash flow-0.50
Discontinued operations0.00
Free Cash Flow-3.79
Total Cash Flow-28.65
4 historic quarters locked

Sign in to unlock the full Gw Pharmaceuticals Plc cash flow history.

Sign In Create Free Account

About GWPH Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.